| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268340 | Journal of Clinical Virology | 2005 | 4 Pages |
Abstract
All the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replication was discovered. A brief description of their mode of action is given.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Yung-Chi Cheng, Chun-Xiao Ying, Chung-Hang Leung, Ying Li,